Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

2.935 +0.075 (+2.62%)
Streaming Delayed Price Updated: 10:05 AM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cerus Corporation - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Closes New Debt Facility of Up to $110 Million
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces First Quarter 2026 Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
From Cerus Corporation
Via Business Wire
News headline image
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026
From Cerus Corporation
Via Business Wire
News headline image
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
From Cerus Corporation
Via Business Wire
News headline image
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Second Quarter 2025 Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Celebrates World Blood Donor Day 2025
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces First Quarter 2025 Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference
From Cerus Corporation
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.